首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues.
【24h】

Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues.

机译:在离子阱质谱仪上通过基质辅助激光解吸电离(MALDI)进行成像质谱(IMS)在生物组织中药物和代谢物分析中的实用性。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: The properties and potential liabilities of drug candidate are investigated in detailed ADME assays and in toxicity studies, where findings are placed in context of exposure to dosed drug and metabolites. The complex nature of biological samples may necessitate work-up procedures prior to high performance liquid chromatography-mass spectrometric (HPLC-MS) analysis of endogenous or xenobiotic compounds. This concept can readily be applied to biological fluids such as blood or urine, but in localized samples such as organs and tissues potentially important spatial, thus anatomical, information is lost during sample preparation as the result of homogenization and extraction procedures. However, the localization of test article or spatial identification of metabolites may be critical to the understanding of the mechanism of target-organ toxicity and its relevance to clinical safety. METHODS: Tissue imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) and ion trap mass spectrometry (MS) with higher order mass spectrometric scanning functions was utilized for localization of dosed drug or metabolite in tissue. Laser capture microscopy (LCM) was used to obtain related samples from tissue for analyses by standard MALDI-MS and HPLC-MS. RESULTS: In a toxicology study, rats were administered with a high dosage of a prodrug for 2 weeks. Birefringent microcrystalline material (10-25 microm) was observed in histopathologic formalin-fixed tissue samples. Direct analysis by IMS provided the identity of material in the microcrystals as circulating active drug while maintaining spatial orientation. Complementary data from visual cross-polarized light microscopy as well as standard MALDI-MS and HPLC-MS experiments on LCM samples validated the qualitative results obtained by IMS. Furthermore, the HPLC-MS analysis on the LCM samples afforded a semi-quantitative assessment of the crystalline material in the tissue samples. DISCUSSION: IMS by MALDI ion trap MS proved sensitive, specific, and highly amenable to the image analysis of traditional small molecule drug candidates directly in tissue.
机译:简介:在详细的ADME分析和毒性研究中对候选药物的特性和潜在责任进行了研究,这些研究结果均与暴露于定量药物和代谢产物的环境有关。生物样品的复杂性质可能需要在内源性或异源性化合物进行高效液相色谱-质谱(HPLC-MS)分析之前进行后处理。该概念可以容易地应用于诸如血液或尿液之类的生物流体,但是由于均质化和提取程序的结果,在局部样品如器官和组织中可能具有重要的空间信息,因此在解剖学上信息会丢失。然而,测试物品的定位或代谢物的空间鉴定对于理解靶器官毒性机制及其与临床安全性的关系可能至关重要。方法:利用具有高阶质谱扫描功能的基质辅助激光解吸电离(MALDI)和离子阱质谱(MS)对组织成像质谱(IMS)进行组织中定量药物或代谢物的定位。使用激光捕获显微镜(LCM)从组织中获取相关样品,以通过标准MALDI-MS和HPLC-MS分析。结果:在毒理学研究中,大鼠接受了高剂量的前药治疗2周。在组织病理学福尔马林固定的组织样品中观察到双折射微晶材料(10-25微米)。 IMS的直接分析提供了微晶中物质作为循环活性药物的身份,同时保持了空间方向。来自视觉交叉偏振光显微镜的补充数据,以及对LCM样品进行的标准MALDI-MS和HPLC-MS实验,验证了IMS的定性结果。此外,对LCM样品的HPLC-MS分析对组织样品中的结晶物质进行了半定量评估。讨论:MALDI离子阱质谱仪的IMS被证明对直接在组织中的传统小分子药物候选者进行图像分析灵敏,特异并且非常适合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号